Lactic acidosis related to nucleoside therapy in HIV-infected patients

Author： Falcó Vicenç Crespo Manuel Ribera Esteban

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.8, 2003-08, pp. : 1321-1329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients

By Harris Marianne

Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. : 389-400

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients

By Fisher Stacy D.

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 383-394

Adis International

Access to resources Recommend Favorite

Cardiovascular risk associated with antiretroviral therapy in HIV-infected patients

By Calza Dr Leonardo Manfredi Roberto Chiodo Francesco

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 11, 2006-11 ,pp. : 1497-1516

Informa Healthcare

Access to resources Recommend Favorite

Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1475-1481

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients

Current Pharmaceutical Design, Vol. 16, Iss. 30, 2010-10 ,pp. : 3379-3389

Bentham Science Publishers

Access to resources Recommend Favorite